The combined RR was 5.55 (95% CI: 1.61–9.49; Z = 2.76; p = 0.006), indicating significant relationship between elevated SALP level and metastatic disease of osteosarcoma patients (Figure 4). Here, KHDRBS3 is linked to metastatic neoplasm.